PuSH - Publikationsserver des Helmholtz Zentrums München

Nontargeted metabolomics using the Sciex ZenoTOF 7600.

In: Metabolomics. Berlin [u.a.]: Springer, 2025. 1-23 (Methods Mol. Biol. ; 2925)
DOI PMC
Nontargeted metabolomics aims to capture as many metabolites as possible present in a biological system under a certain condition. Despite several analytical techniques commonly applied for nontargeted metabolomics, liquid chromatography coupled to high-resolution tandem mass spectrometry (LC-HRMS/MS) is one of the most employed techniques. To cover broad metabolic classes, different chromatographic separation techniques are implemented, i.e., reversed-phase (RP) and hydrophilic interaction liquid chromatography (HILIC) techniques. Each method offers a complementary polarity range. While RP covers semi- to nonpolar metabolites, such as fatty acids, acylcarnitines, steroids, bile acids, etc., HILIC allows the analysis of polar metabolites, such as amino acids, amines, and organic acids.Nontargeted metabolomics platforms at Helmholtz Munich have been validated for various biological matrices, including biological liquids (plasma, serum, urine), tissues (liver, heart), and cell samples of human and rodent. Analysis is based on the Sciex ZenoTOF 7600 and three chromatographic separation methods, which can be used individually or in combination.
Altmetric
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Sammelbandbeitrag/Buchkapitel
Schlagwörter Hydrophilic Interaction Liquid Chromatography (hilic) ; Lc-hrms/ms ; Metabolomics ; Non-targeted ; Reversed Phase (rp)
Sprache englisch
Veröffentlichungsjahr 2025
HGF-Berichtsjahr 2025
ISSN (print) / ISBN 1064-3745
e-ISSN 1940-6029
Bandtitel Metabolomics
Quellenangaben Band: 2925, Heft: , Seiten: 1-23 Artikelnummer: , Supplement: ,
Verlag Springer
Verlagsort Berlin [u.a.]
Begutachtungsstatus Peer reviewed
POF Topic(s) 30505 - New Technologies for Biomedical Discoveries
Forschungsfeld(er) Enabling and Novel Technologies
PSP-Element(e) A-630710-001
Scopus ID 105008743507
PubMed ID 40498178
Erfassungsdatum 2025-06-30